- Report
- May 2024
- 344 Pages
Global
From €5197EUR$6,231USD£4,350GBP
- Report
- April 2024
- 310 Pages
Global
From €5197EUR$6,231USD£4,350GBP
- Report
- April 2024
- 318 Pages
Global
From €5197EUR$6,231USD£4,350GBP
- Report
- February 2024
- 280 Pages
Global
From €5197EUR$6,231USD£4,350GBP
- Report
- February 2024
- 322 Pages
Global
From €5197EUR$6,231USD£4,350GBP
- Report
- February 2024
- 213 Pages
Global
From €5197EUR$6,231USD£4,350GBP
- Report
- January 2024
- 348 Pages
Global
From €5197EUR$6,231USD£4,350GBP
- Report
- December 2024
- 340 Pages
Global
From €5197EUR$6,231USD£4,350GBP
- Report
- July 2024
- 288 Pages
Global
From €5197EUR$6,231USD£4,350GBP
- Report
- October 2023
- 284 Pages
Global
From €4719EUR$5,658USD£3,950GBP
- Report
- August 2023
- 334 Pages
Global
From €4719EUR$5,658USD£3,950GBP
- Report
- July 2023
- 224 Pages
Global
From €4719EUR$5,658USD£3,950GBP
- Report
- May 2023
- 187 Pages
Global
From €4719EUR$5,658USD£3,950GBP
- Report
- January 2023
- 262 Pages
Global
From €4719EUR$5,658USD£3,950GBP
- Report
- December 2022
- 196 Pages
Global
From €4719EUR$5,658USD£3,950GBP
- Report
- November 2022
- 285 Pages
Global
From €4719EUR$5,658USD£3,950GBP
- Report
- November 2022
- 353 Pages
Global
From €4719EUR$5,658USD£3,950GBP
- Report
- January 2023
- 248 Pages
Global
From €4719EUR$5,658USD£3,950GBP
- Report
- October 2024
- 220 Pages
Global
From €4143EUR$4,799USD£3,589GBP
- Report
- August 2018
- 340 Pages
Global
From €3020EUR$3,499USD£2,617GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more